Navigation

Published technology appraisals

This table lists published NICE technology appraisals. The list can be sorted by title (alphabetically), issue date and review date. You can also:

  • click the appraisal title for full details
  • click a column heading to sort the list by that column

Please note that the 'review date' is not the date when a review of it the appraisal starts, but the date NICE consults on a proposal for reviewing it. There is no guarantee that at the review date, a review will be undertaken. Appraisals which have been considered for review and where the decision has been not to carry out a review at this time are listed in static technology appraisals.

More information on the published appraisals list.

For technology appraisal guidance organised by category, use Find guidance in the main header area above.

Searching for specific technology appraisal guidance?

Published appraisals

Results 101-120 of 308

Ref Title Date Issued Review
TA101 Prostate cancer (hormone-refractory) - docetaxel (TA101) Jun 2006 Jun 2009
TA102 Conduct disorder in children - parent-training/education programmes (TA102) (replaced by CG158) Jul 2006 TBC
TA103 Psoriasis - efalizumab and etanercept (TA103) Jul 2006 TBC
TA104 Psoriatic arthritis - etanercept and infliximab (TA104) (replaced by TA199) Jul 2006 TBC
TA105 Colorectal cancer - laparoscopic surgery (review) (TA105) Aug 2006 Sep 2009
TA106 Hepatitis C - peginterferon alfa and ribavirin (TA106) Aug 2006 TBC
TA107 Breast cancer (early) - trastuzumab (TA107) Aug 2006 TBC
TA108 Breast cancer (early) - paclitaxel (TA108) Sep 2006 TBC
TA109 Breast cancer (early) - docetaxel (TA109) Sep 2006 TBC
TA110 Follicular lymphoma - rituximab (TA110) (replaced by TA243) Sep 2006 Jun 2009
TA111 Alzheimer's disease - donepezil, galantamine, rivastigmine (review) and memantine (replaced by TA217) (TA111) (withdrawn) Sep 2007 TBC
TA112 Breast cancer (early) - hormonal treatments (TA112) Nov 2006 Jun 2009
TA113 Diabetes (type 1 and 2) - inhaled insulin (withdrawn) (TA113) (withdrawn) Dec 2006 TBC
TA114 Drug misuse - methadone and buprenorphine (TA114) Jan 2007 TBC
TA115 Drug misuse - naltrexone (TA115) Jan 2007 TBC
TA116 Breast cancer - gemcitabine (TA116) Jan 2007 Jan 2010
TA117 Hyperparathyroidism - cinacalcet (TA117) Jan 2007 Dec 2009
TA118 Colorectal cancer (metastatic) - bevacizumab and cetuximab (TA118) (partially updated by TA242) Jan 2007 May 2009
TA119 Leukaemia (lymphocytic) - fludarabine (TA119) Feb 2007 Oct 2009
TA120 Heart failure - cardiac resynchronisation (TA120) May 2007 TBC

This page was last updated: 16 April 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.